As more fully described in Item 5 of this Amendment No. 4 (as defined in Item 1 below), such shares and percentage are based on 20,913,373 shares of common stock, par value $0.0001 per share, of the Issuer (the "Common Stock") outstanding, consisting of (a) 4,151,259 shares of Common Stock as of July 7, 2026 as disclosed in the definitive proxy statement filed by the Issuer with the U.S. Securities and Exchange Commission ("SEC") on July 17, 2026 (the "Proxy Statement"), (b) 256,105 shares of Common Stock issued to 3i, LP on July 19, 2026 pursuant to conversions of certain shares of Series B Preferred Stock (as defined below), (c) 846,666 shares of Common Stock issued to 3i, LP on August 12, 2026 pursuant to conversions of certain shares of Series B Preferred Stock, (d) 9,260,042 shares of Common Stock issued to 3i, LP on August 12, 2026 pursuant to conversions of certain shares of Series C Preferred Stock (as defined below), (e) 1,262,733 shares of Common Stock issued to 3i, LP on August 13, 2026 pursuant to conversion of certain shares of Series C Preferred Stock, (f) 3,116,164 shares of Common Stock issued to 3i, LP on August 17, 2026 pursuant to conversion of certain shares of Series C Preferred Stock and (g) 2,020,404 shares of Common Stock issued to 3i, LP on August 20, 2026 pursuant to conversion of certain shares of Series C Preferred Stock. Beneficial ownership consists of 1,967,298 shares of Common Stock directly held by 3i, LP and 135,482 shares of Common Stock issuable in any combination upon (i) exercises of certain common stock purchase warrants (the "Warrants") held directly by 3i, LP, which exercises are subject to a 9.99% beneficial ownership limitation provision (a "Blocker"), (ii) conversions of a senior secured convertible note in the original principal amount of $16,253,147.10 (the "Note") held directly by 3i, LP, which conversions are subject to a Blocker, (iii) conversions of shares of Series B Convertible Preferred Stock, par value $0.0001 per share, of the Issuer (the "Series B Preferred Stock") directly held by 3i, LP, which conversions are subject to a Blocker, and (iv) conversions of shares of Series C Convertible Preferred Stock, par value $0.0001 per share, of the Issuer (the "Series C Preferred Stock") directly held by the 3i, LP, which conversions are subject to a Blocker.

As more fully described in Item 5 of this Amendment No. 4, such shares and percentage are based on 20,913,373 shares of Common Stock outstanding, consisting of (a) 4,151,259 shares of Common Stock as of July 7, 2026 as disclosed in the Proxy Statement, (b) 256,105 shares of Common Stock issued to 3i, LP on July 19, 2026 pursuant to conversions of certain shares of Series B Preferred Stock, (c) 846,666 shares of Common Stock issued to 3i, LP on August 12, 2026 pursuant to conversions of certain shares of Series B Preferred Stock, (d) 9,260,042 shares of Common Stock issued to 3i, LP on August 12, 2026 pursuant to conversions of certain shares of Series C Preferred Stock, (e) 1,262,733 shares of Common Stock issued to 3i, LP on August 13, 2026 pursuant to conversions of certain shares of Series C Preferred Stock, (f) 3,116,164 shares of Common Stock issued to 3i, LP on August 17, 2026 pursuant to conversions of certain shares of Series C Preferred Stock and (g) 2,020,404 shares of Common Stock issued to 3i, LP on August 20, 2026 pursuant to conversion of certain shares of Series C Preferred Stock. Beneficial ownership consists of 1,967,298 shares of Common Stock indirectly held by the reporting person and 135,482 shares of Common Stock issuable in any combination upon (i) exercises of the Warrants indirectly held by the reporting person, which exercises are in each case subject to a Blocker, and (ii) conversions of the Note, shares of Series B Preferred Stock and shares of Series C Preferred Stock indirectly held by the reporting person, which conversions are in each case subject to a Blocker.

As more fully described in Item 5 of this Amendment No. 4, such shares and percentage are based on 20,913,373 shares of Common Stock outstanding, consisting of (a) 4,151,259 shares of Common Stock as of July 7, 2026 as disclosed in the Proxy Statement, (b) 256,105 shares of Common Stock issued to 3i, LP on July 19, 2026 pursuant to conversions of certain shares of Series B Preferred Stock, (c) 846,666 shares of Common Stock issued to 3i, LP on August 12, 2026 pursuant to conversions of certain shares of Series B Preferred Stock, (d) 9,260,042 shares of Common Stock issued to 3i, LP on August 12, 2026 pursuant to conversions of certain shares of Series C Preferred Stock, (e) 1,262,733 shares of Common Stock issued to 3i, LP on August 13, 2026 pursuant to conversions of certain shares of Series C Preferred Stock, (f) 3,116,164 shares of Common Stock issued to 3i, LP on August 17, 2026 pursuant to conversions of certain shares of Series C Preferred Stock and (g) 2,020,404 shares of Common Stock issued to 3i, LP on August 20, 2026 pursuant to conversion of certain shares of Series C Preferred Stock. Beneficial ownership consists of 1,967,298 shares of Common Stock indirectly held by the reporting person and 135,482 shares of Common Stock issuable in any combination upon (i) exercises of the Warrants indirectly held by the reporting person, which exercises are in each case subject to a Blocker, and (ii) conversions of the Note, shares of Series B Preferred Stock and shares of Series C Preferred Stock indirectly held by the reporting person, which conversions are in each case subject to a Blocker.